Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04897113
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:09.859769+00:00
Published At
2021-05-21T00:00:00+00:00
Record Updated At
2021-05-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hypercholesterolemia", "Hyperbilirubinemia", "Hyper IgE Syndrome", "Hyper Beta Lipoproteinemia", "Hyper Eosinophilic Syndrome", "Hyper-LDL-cholesterolemia", "Gout", "Diabetes", "Nervous System Diseases", "Neuromuscular Diseases", "Cardiovascular Diseases", "Urologic Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-21"
protocolSection.identificationModule.nctId
"NCT04897113"
protocolSection.identificationModule.officialTitle
"Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hypercholesterolemia (protocolSection.conditionsModule.conditions)
  • Hyperbilirubinemia (protocolSection.conditionsModule.conditions)
  • Hyper IgE Syndrome (protocolSection.conditionsModule.conditions)
  • Hyper Beta Lipoproteinemia (protocolSection.conditionsModule.conditions)
  • Hyper Eosinophilic Syndrome (protocolSection.conditionsModule.conditions)
  • Hyper-LDL-cholesterolemia (protocolSection.conditionsModule.conditions)
  • Gout (protocolSection.conditionsModule.conditions)
  • Diabetes (protocolSection.conditionsModule.conditions)
  • Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Neuromuscular Diseases (protocolSection.conditionsModule.conditions)
  • Cardiovascular Diseases (protocolSection.conditionsModule.conditions)
  • Urologic Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.